China Universal Asset Management Company’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

China Universal Asset Management Company’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,414	Closed	-$3.04K	–	487
2023 Q3	$3.04K	Buy	1,414 +693	+96%	+$2.77K	﹤0.01%	416
2023 Q2	$4.04K	Sell	721 -25	-3%	-$196	﹤0.01%	387
2023 Q1	$4.5K	Buy	746 +258	+53%	+$1.8K	﹤0.01%	375
2022 Q4	$2.79K	Buy	488 +40	+9%	+$225	﹤0.01%	351
2022 Q3	$2K	Buy	+448	New	+$2.27K	﹤0.01%	366

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

China Universal Asset Management Company's OMGA Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2023, closing a stake of 1,414 shares — an estimated $3.04K sold.

China Universal Asset Management Company first reported a position in OMGA in Q3 2022 and held it in 5 quarters. The position peaked at $4.5K in Q1 2023. 63 funds tracked by Wall St. Rank hold OMGA as of Q4 2023.

China Universal Asset Management Company reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 1,414 Omega Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $3.04K.
China Universal Asset Management Company first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's Omega Therapeutics, Inc. Common Stock position peaked at $4.5K in Q1 2023.
63 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.